Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies.
Autor: | Zouiouich S; Section of Nutrition and Metabolism, International Agency for Research on Cancer-WHO, Lyon, France. semi.zouiouich@nih.gov., Loftfield E; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Huybrechts I; Section of Nutrition and Metabolism, International Agency for Research on Cancer-WHO, Lyon, France., Viallon V; Section of Nutrition and Metabolism, International Agency for Research on Cancer-WHO, Lyon, France., Louca P; Department of Twin Research, King's College London, London, UK., Vogtmann E; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Wells PM; Department of Twin Research, King's College London, London, UK., Steves CJ; Department of Twin Research, King's College London, London, UK., Herzig KH; Research Unit of Biomedicine, Medical Research Center (MRC), University of Oulu, University Hospital, Oulu, Finland.; Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, Poznan, Poland., Menni C; Department of Twin Research, King's College London, London, UK., Jarvelin MR; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.; Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Unit of Primary Health Care, Oulu University Hospital, OYS, Oulu, Finland.; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, UK., Sinha R; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Gunter MJ; Section of Nutrition and Metabolism, International Agency for Research on Cancer-WHO, Lyon, France. |
---|---|
Jazyk: | angličtina |
Zdroj: | Diabetologia [Diabetologia] 2021 Aug; Vol. 64 (8), pp. 1749-1759. Date of Electronic Publication: 2021 Jun 10. |
DOI: | 10.1007/s00125-021-05464-w |
Abstrakt: | Aims/hypothesis: The gut microbiome is hypothesised to be related to insulin resistance and other metabolic variables. However, data from population-based studies are limited. We investigated associations between serologic measures of metabolic health and the gut microbiome in the Northern Finland Birth Cohort 1966 (NFBC1966) and the TwinsUK cohort. Methods: Among 506 individuals from the NFBC1966 with available faecal microbiome (16S rRNA gene sequence) data, we estimated associations between gut microbiome diversity metrics and serologic levels of HOMA for insulin resistance (HOMA-IR), HbA Results: In NFBC1966, alpha diversity was lower in individuals with higher HOMA-IR with a mean of 74.4 (95% CI 70.7, 78.3) amplicon sequence variants (ASVs) for the first quartile of HOMA-IR and 66.6 (95% CI 62.9, 70.4) for the fourth quartile of HOMA-IR. Alpha diversity was also lower with higher HbA Conclusions/interpretation: Overall, higher levels of HOMA-IR, CRP and HbA |
Databáze: | MEDLINE |
Externí odkaz: |